Benedectin.

Suppliers

Names

[ CAS No. ]:
8064-77-5

[ Name ]:
Benedectin.

Chemical & Physical Properties

[ Boiling Point ]:
399.8ºC at 760 mmHg

[ Melting Point ]:
207ºC

[ Molecular Formula ]:
C8H12ClNO3

[ Molecular Weight ]:
205.63900

[ Flash Point ]:
116.5ºC

[ Exact Mass ]:
205.05100

[ PSA ]:
73.58000

[ LogP ]:
0.88220

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
EJ9960000
CAS REGISTRY NUMBER :
8064-77-5
LAST UPDATED :
199806
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C19-H35-N-O2.C17-H22-N2-O.C8-H11-N-O3.C4-H6-O4.2Cl-H
MOLECULAR WEIGHT :
940.18

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
75600 ug/kg
SEX/DURATION :
female 6-11 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Effects on Newborn - stillbirth
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 1,691,1978
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
67 mg/kg
SEX/DURATION :
female 4-20 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - gastrointestinal system
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 1,925,1978
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
60 mg/kg
SEX/DURATION :
female 4-18 week(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion Reproductive - Effects on Embryo or Fetus - other effects to embryo Reproductive - Specific Developmental Abnormalities - body wall
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 1,691,1978
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
60 mg/kg
SEX/DURATION :
female 4-18 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 1,691,1978
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
648 mg/kg
SEX/DURATION :
female 1-39 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - urogenital system
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 1,691,1978
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
648 mg/kg
SEX/DURATION :
female 1-39 week(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 1,691,1978

Related Compounds

  • 1-ethyl-N-(6-methoxybenzo[d]thiazol-2-yl)-N-(pyridin-2-ylmethyl)-1H-pyrazole-3-carboxamide
  • 4-[5-(2-Chlorophenyl)-1,2,4-oxadiazol-3-yl]aniline
  • 4-(5-Cyclobutyl-1,2,4-oxadiazol-3-yl)aniline
  • 4-[5-(2,2-Dimethylpropyl)-1,2,4-oxadiazol-3-yl]aniline
  • 3-[5-(2-Chlorophenyl)-1,2,4-oxadiazol-3-yl]aniline
  • Benzenamine, 3-[5-(2-iodophenyl)-1,2,4-oxadiazol-3-yl]-
  • 4-Ethyl-3-(1-hydroxyethyl)-1H-1,2,4-triazol-5(4H)-one
  • 2-Acetamido-5-methoxy-4-(2-methoxyethoxy)benzoic acid
  • 4-Methyl-N-2-pyrazinyl-2-quinolinamine
  • 1-(5-Bromo-2-fluorophenyl)-1h-1,2,3-triazole-5-carboxylic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.